Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04722185 · ClinicalTrials.gov registry record · NA
Evaluation of the Veriton SPECT/CT System
A NA study of Focus of Study is Comparison of 2 Types of Gamma Cameras, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 1
- Study location
NCT04722185: Completed NA study of Focus of Study is Comparison of 2 Types of Gamma Cameras, sponsored by Mayo Clinic.
NCT04722185 is a NA study of Focus of Study is Comparison of 2 Types of Gamma Cameras that has completed, run by Mayo Clinic. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04722185, a NA study of Focus of Study is Comparison of 2 Types of Gamma Cameras, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to evaluate a new type of gamma camera (the Veriton system) that provides a significant gain in system sensitivity and improved image quality compared to a conventional gamma camera that can achieve equal or better image quality than a standard SPECT/CT system.
Primary Outcome
Assessment of relative image quality between the Veriton system and a conventional gamma camera as a function of the type of nuclear medicine exam.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Veriton SPECT/CT
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2021-01-20 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the finished NCT04722185 record still lists
NCT04722185 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Focus of Study is Comparison of 2 Types of Gamma Cameras appearing as the primary indexed condition, and to 1 intervention - of which Veriton SPECT/CT is the first listed.
NCT04722185 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04722185 about?
NCT04722185 is a clinical study titled "Evaluation of the Veriton SPECT/CT System". The main purpose of this study is to evaluate a new type of gamma camera (the Veriton system) that provides a significant gain in system sensitivity and improved image quality compared to a conventional gamma camera that can achieve equal or better image quality than a standard SPECT/CT system.
What is the current status of trial NCT04722185?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2021-01-20. Estimated completion is 2025-12-31.
What conditions does trial NCT04722185 study?
This clinical trial studies the following conditions: Focus of Study is Comparison of 2 Types of Gamma Cameras.
What interventions are being tested in trial NCT04722185?
The interventions under investigation include: Veriton SPECT/CT (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04722185?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04722185 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04722185's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI